Abstract

Medication Adherence after Myocardial Infarction: The Impact of Anxiety and Depression

References

  1. Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., ... & Muntner, P. (2017). Heart disease and stroke statistics—2017 update: a report from the American Heart Association. circulation, 135(10), e146-e603.‏
  2. WHO. (2022). Jordan implements WHO HEARTS in primary health care to strengthen management of cardiovascular diseases and related risks. 2023 as cited in: https://www.emro.who.int/jor/jordan-infocus/jordan-implements-who-hearts-in-primary-health-care-to-strengthen-management-of-cardiovascular-diseases-and-related-risks.html
  3. Elhneiti, M., & Al-Hussami, M. (2017). Predicting risk factors of heart disease among Jordanian patients. Health, 9(02), 237.‏
  4. Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018). Executive group on behalf of the joint European society of cardiology (ESC)/American college of cardiology (ACC)/American heart association (AHA)/World heart federation (WHF) task force for the universal definition of myocardial infarction. Fourth universal definition of myocardial infarction (2018). Circulation, 138(20), e618-e651.‏
  5. Kosobucka, A., Michalski, P., Pietrzykowski, Ł., Kasprzak, M., Obońska, K., Fabiszak, T., ... & Kubica, A. (2018). Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction. Patient preference and adherence, 333-340.‏
  6. Basheti, I. A., El Hait, S. S., Qunaibi, E. A., Aburuz, S., & Bulatova, N. (2016). Associations between patient factors and medication adherence: a Jordanian experience. Pharmacy Practice (Granada), 14(1), 0-0.‏
  7. Shah, D., Simms, K., Barksdale, D. J., & Wu, J. R. (2015). Improving medication adherence of patients with chronic heart failure: challenges and solutions. Research Reports in Clinical Cardiology, 87-95.‏
  8. Pednekar, P. P., Agh, T., Malmenäs, M., Raval, A. D., Bennett, B. M., Borah, B. J., ... & Peterson, A. M. (2019). Methods for measuring multiple medication adherence: a systematic review–report of the ISPOR medication adherence and persistence special interest group. Value In Health, 22(2), 139-156.‏
  9. Liu, J., Zhu, X., Yan, J., Gong, L., Wu, X., Liu, M., & Mao, P. (2021). Association Between Regulatory Emotional Self-Efficacy and Immunosuppressive Medication Adherence in Renal Transplant Recipients: Does Medication Belief Act as a Mediator?. Frontiers in Pharmacology, 12, 559368.‏
  10. Feng, H. P., Chien, W. C., Cheng, W. T., Chung, C. H., Cheng, S. M., & Tzeng, W. C. (2016). Risk of anxiety and depressive disorders in patients with myocardial infarction: A nationwide population-based cohort study. Medicine, 95(34).‏
  11. Murphy, B., Le Grande, M., Alvarenga, M., Worcester, M., & Jackson, A. (2020). Anxiety and depression after a cardiac event: prevalence and predictors. Frontiers in psychology, 10, 3010.‏
  12. Riegel, B. (2014). The Role of Depression in Medication Adherence Among Heart Failure Patients. Clinical Nursing Research, 23 (3), 231-244. http://dx.doi.org/10.1177/1054773813481801
  13. Grenard, JL., Munjas, BA., Adams, JL., Suttorp, M., Maglione, M., McGlynn, EA., Gellad, WF. (2011). Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 26 (10):1175-82. doi: 10.1007/s11606-011-1704-y. Epub 2011 May 1. PMID: 21533823; PMCID: PMC3181287.
  14. Canali, G., Tittle, V., & Seita, A. (2018). Medication adherence by Palestine refugees living in Jordan who have diabetes: a cross-sectional study. The Lancet, 391, S13.‏
  15. Jarab, A. S., Rababa'h, A. M., Almousa, A., Mukattash, T. L., & Bsoul, R. (2020). Non-adherence to pharmacotherapy and its associated factors among patients with angina in Jordan. Journal of Pharmaceutical Health Services Research, 11(1), 61-65.‏
  16. ESC Committee for Practice Guidelines (CPG), Jeroen J. Bax (CPG Chairperson)(The Netherlands), Helmut Baumgartner (Germany), Claudio Ceconi (Italy), Veronica Dean (France), Christi Deaton (UK), ... & Mendis, S. (2012). Third universal definition of myocardial infarction. Journal of the American College of Cardiology, 60(16), 1581-1598.‏
  17. Williams, R. B., Barefoot, J. C., Califf, R. M., Haney, T. L., Saunders, W. B., Pryor, D. B., ... & Mark, D. B. (1992). Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. Jama, 267(4), 520-524.‏
  18. Naqvi, AA., Hassali, MA., Rizvi, M., Zehra, A., Iffat, W., Haseeb, A., Jamshed, S. (2018). Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan. Front Pharmacol. 9:1124. doi: 10.3389/fphar.2018.01124. PMID: 30356775; PMCID: PMC6189444.
  19. Meng, X., Li, D., Li, S., Lv, Q., Wang, X., Wang, Y., ... & Wang, L. (2022). Rasch Analysis of Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in China.‏
  20. Mahmoud, M. A., Islam, M. A., Ahmed, M., Bashir, R., Ibrahim, R., Al-Nemiri, S., ... & Yousif, M. A. (2021). Validation of the arabic version of general medication adherence scale (GMAS) in sudanese patients with diabetes mellitus. Risk management and healthcare policy, 4235-4241.‏
  21. Zigmond, AS., Snaith, RP. (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x. PMID: 6880820.
  22. Terkawi, A. S., Tsang, S., AlKahtani, G. J., Al-Mousa, S. H., Al Musaed, S., AlZoraigi, U. S., ... & Altirkawi, K. A. (2017). Development and validation of Arabic version of the Hospital Anxiety and Depression Scale. Saudi journal of anaesthesia, 11(5), 11.‏
  23. Murphy, B. M., Higgins, R. O., & Jackson, A. C. (2016). Anxiety, depression, and psychological adjustment after an acute cardiac event. Handbook of psychocardiology.‏
  24. Kala, P., Hudakova, N., Jurajda, M., Kasparek, T., Ustohal, L., Parenica, J., ... & Kanovsky, J. (2016). Depression and anxiety after acute myocardial infarction treated by primary PCI. PLoS One, 11(4), e0152367.‏
  25. Watkins, L. L., Koch, G. G., Sherwood, A., Blumenthal, J. A., Davidson, J. R., O'Connor, C., & Sketch Jr, M. H. (2013). Association of anxiety and depression with all‐cause mortality in individuals with coronary heart disease. Journal of the American Heart Association, 2(2), e000068.‏
  26. Wu, Y. T., Kralj, C., Acosta, D., Guerra, M., Huang, Y., Jotheeswaran, A. T., ... & Prina, A. M. (2020). The association between, depression, anxiety, and mortality in older people across eight low‐and middle‐income countries: Results from the 10/66 cohort study. International journal of geriatric psychiatry, 35(1), 29-36.‏
  27. Shang, P., Liu, G. G., Zheng, X., Ho, P. M., Hu, S., Li, J., ... & Krumholz, H. M. (2019). Association between medication adherence and 1‐year major cardiovascular adverse events after acute myocardial infarction in China. Journal of the American Heart Association, 8(9), e011793.‏
  28. Castellano, J. M., Fuster, V., Jennings, C., Prescott, E., & Bueno, H. (2017). Role of the polypill for secondary prevention in ischaemic heart disease. European journal of preventive cardiology, 24(3_suppl), 44-51.‏
  29. Collet, J. P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., ... & Karia, N. (2021). 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European heart journal, 42(14), 1289-1367.‏
  30. Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., ... & Bax, J. J. (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal, 41(3), 407-477.‏
  31. Du, L., Cheng, Z., Zhang, Y., Li, Y., & Mei, D. (2017). The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis. European journal of preventive cardiology, 24(9), 962-970.‏
  32. Dempe, C., Jünger, J., Hoppe, S., Katzenberger, M. L., Möltner, A., Ladwig, K. H., ... & Schultz, J. H. (2013). Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. Journal of psychosomatic research, 74(2), 122-127.‏
  33. Lissåker, C. T., Wallert, J., Held, C., & Olsson, E. (2017). Emotional distress as a predictor of statin non-adherence among Swedish first-time myocardial infarction patients, 2006–2013. Journal of Psychosomatic Research, 97, 30-37.‏
  34. Sandoval, D., Chacón, J., Muñoz, R., Henríquez, Ó., Koch, E., & Romero, T. (2014). Influence of psychosocial factors on adherence to antihypertensive drug therapy. Results from a Cardiovascular Health Program cohort followed in the Metropolitan Region of Santiago, Chile Influencia de factores psicosociales en la adherencia al tratamient.‏
  35. Tang, H. Y., Sayers, S. L., Weissinger, G., & Riegel, B. (2014). The role of depression in medication adherence among heart failure patients. Clinical nursing research, 23(3), 231-244.‏
  36. Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. (2014). Depression and cardiovascular disease: a clinical review. European heart journal, 35(21), 1365-1372.‏
  37. Carney, R. M., Freedland, K. E., Eisen, S. A., Rich, M. W., Skala, J. A., & Jaffe, A. S. (1998). Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behavioral Medicine, 24(1), 35-39.‏
  38. Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. Journal of psychosomatic research, 42(1), 17-41.‏